Market Closed -
London S.E.
09:05:11 03/05/2024 pm IST
|
5-day change
|
1st Jan Change
|
7.25
GBX
|
0.00%
|
|
0.00%
|
-25.64%
|
Fiscal Period: December |
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
---|
Capitalization
1 |
82.92
|
75.13
|
21.29
|
17.58
|
17.58
|
-
|
Enterprise Value (EV)
1 |
70.05
|
66.86
|
21.29
|
19.1
|
19.11
|
18.84
|
P/E ratio
|
-
|
-
|
-2.25
x
|
-
|
-
|
-
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
-
|
-
|
-
|
22.2
x
|
2.98
x
|
1.72
x
|
EV / Revenue
|
-
|
-
|
-
|
24.1
x
|
3.24
x
|
1.84
x
|
EV / EBITDA
|
-68.9
x
|
-11.6
x
|
-
|
-3.25
x
|
-4.98
x
|
18.8
x
|
EV / FCF
|
-110
x
|
-12
x
|
-
|
-3.36
x
|
-3.17
x
|
-69
x
|
FCF Yield
|
-0.91%
|
-8.32%
|
-
|
-29.8%
|
-31.5%
|
-1.45%
|
Price to Book
|
3.37
x
|
7.83
x
|
-
|
4.71
x
|
3.83
x
|
3.65
x
|
Nbr of stocks (in thousands)
|
1,41,748
|
1,41,748
|
1,70,319
|
2,42,541
|
2,42,541
|
-
|
Reference price
2 |
0.5850
|
0.5300
|
0.1250
|
0.0725
|
0.0725
|
0.0725
|
Announcement Date
|
14/04/21
|
19/05/22
|
05/06/23
|
-
|
-
|
-
|
Fiscal Period: December |
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
---|
Net sales
1 |
-
|
-
|
-
|
0.791
|
5.907
|
10.25
|
EBITDA
1 |
-1.017
|
-5.765
|
-
|
-5.877
|
-3.834
|
1
|
EBIT
1 |
-3.182
|
-6.715
|
-
|
-6.729
|
-4.756
|
0.027
|
Operating Margin
|
-
|
-
|
-
|
-850.7%
|
-80.51%
|
0.26%
|
Earnings before Tax (EBT)
|
-
|
-
|
-
|
-
|
-
|
-
|
Net income
|
-
|
-
|
-9.185
|
-
|
-
|
-
|
Net margin
|
-
|
-
|
-
|
-
|
-
|
-
|
EPS
|
-
|
-
|
-0.0556
|
-
|
-
|
-
|
Free Cash Flow
1 |
-0.638
|
-5.562
|
-
|
-5.684
|
-6.026
|
-0.273
|
FCF margin
|
-
|
-
|
-
|
-718.58%
|
-102.01%
|
-2.66%
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
14/04/21
|
19/05/22
|
05/06/23
|
-
|
-
|
-
|
Fiscal Period: December |
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
---|
Net Debt
1 |
-
|
-
|
-
|
1.52
|
1.53
|
1.25
|
Net Cash position
1 |
12.9
|
8.27
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-0.2583
x
|
-0.3985
x
|
1.254
x
|
Free Cash Flow
1 |
-0.64
|
-5.56
|
-
|
-5.68
|
-6.03
|
-0.27
|
ROE (net income / shareholders' equity)
|
-
|
-
|
-
|
-
|
-
|
-
|
ROA (Net income/ Total Assets)
|
-
|
-
|
-
|
-
|
-
|
-
|
Assets
|
-
|
-
|
-
|
-
|
-
|
-
|
Book Value Per Share
2 |
0.1700
|
0.0700
|
-
|
0.0200
|
0.0200
|
0.0200
|
Cash Flow per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
Capex
|
-
|
-
|
-
|
-
|
-
|
-
|
Capex / Sales
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
14/04/21
|
19/05/22
|
05/06/23
|
-
|
-
|
-
|
Last Close Price
0.0725
GBP Average target price
0.2
GBP Spread / Average Target +175.86% Consensus |
1st Jan change
|
Capi.
|
---|
| -25.64% | 22.07M | | -1.89% | 12.56B | | -9.59% | 7.68B | | -1.31% | 5.29B | | +21.82% | 5.24B | | +0.02% | 4.57B | | -50.89% | 3.29B | | +6.42% | 2.6B | | -10.02% | 2.2B | | -8.29% | 1.79B |
Diagnostic & Testing Substances
|